Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

October 24, 2024

Study Completion Date

November 23, 2024

Conditions
Nerve BlockAnesthesia, LocalForearm FractureSurgeryBrachial Plexus Block
Interventions
DRUG

Ropivacaine 0.5% Injectable Solution

30 mL Ropivacaine 5 mg/mL (= 150 mg Ropivacaine)

DRUG

Lidocaine epinephrine

20 mL Ropivacaine 5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg) / ml (= 100 mg Ropivacaine + 200 mg Lidocaine)

DRUG

Ropivacaine 0.75% Injectable Solution

20 mL Ropivacaine 7,5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg)/mL (= 150 mg Ropivacaine + 200 mg Lidocaine)

Trial Locations (1)

3400

Nordsjælland Hospital, Hillerød

All Listed Sponsors
lead

Nordsjaellands Hospital

OTHER

NCT06381622 - Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block | Biotech Hunter | Biotech Hunter